PEGylated single-walled carbon nanotubes activate neutrophils to increase production of hypochlorous acid, the oxidant capable of degrading nanotubes

Toxicology and Applied Pharmacology

Volumn 264, Issue 1, 2012, Pages 131-142

  Vlasova, Irina I ^a   Vakhrusheva, Tatyana V ^a   Sokolov, Alexey V ^a,b   Kostevich, Valeria A ^a,b   Gusev, Alexandr A ^a   Gusev, Sergey A ^a   Melnikova, Viktoriya I ^c   Lobach, Anatolii S ^d  

^a FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^c KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

^d INSTITUTE OF PROBLEMS OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

Carbon nanotubes; Hypochlorite; Macrophages; Myeloperoxidase; Neutrophils

Indexed keywords

HYPOCHLOROUS ACID; MACROGOL; SINGLE WALLED NANOTUBE; ZYMOSAN;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADATION; BLOOD SAMPLING; CONTROLLED STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOUSE; NEUTROPHIL; NONHUMAN;

ANIMALS; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MALE; MICE; MICE, INBRED CBA; NANOTUBES, CARBON; NEUTROPHIL ACTIVATION; NEUTROPHILS; OXIDANTS; PERITONEAL CAVITY; PEROXIDASE; POLYETHYLENE GLYCOLS; SODIUM HYPOCHLORITE;

MUS;

EID: 84865970028     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.07.027     Document Type: Article

References (76)

1. Allen B.L., Kichambare P.D., Gou P., Vlasova I.I., Kapralov A.A., Konduru N.V., Kagan V.E., Star A. Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. Nano Lett. 2008, 8:3899-3903.
2. Allen B.L., Kotchey G.P., Chen Y., Yanamala N.V., Klein-Seetharaman J., Kagan V.E., Star A. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J. Am. Chem. Soc. 2009, 131:17194-17205.
3. Arnhold J., Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch. Biochem. Biophys. 2010, 500:92-106.
4. Bakkenist A.R.J., De Boer J.E.G., Plat H., Wever R. The halide complexes of myeloperoxidase and the mechanism of the halogenation reactions. Biochim. Biophys. Acta 1980, 613:337-348.
5. Bartneck M., Keul H.A., Zwadlo-Klarwasser G., Groll J. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 2010, 10:56-63.
6. Bianco A., Kostarelos K., Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem. Commun. (Camb.) 2011, 47:10182-10188.
7. Bottini M., Rosato N., Bottini N. PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. Biomacromolecules 2011, 12:3381-3393.
8. Burke A., Ding X., Singh R., Kraft R.A., Levi-Polyachenko N., Rylander M.N., Szot C., Buchanan C., Whitney J., Fisher J., Hatcher H.C., D'Agostino R., Kock N.D., Ajayan P.M., Carroll D.L., Akman S., Torti F.M., Torti S.V. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12897-12902.
9. Cheng J., Meziani M.J., Sun Y.-P., Cheng S.H. Poly(ethylene glycol)-conjugated multi-walled carbon nanotubes as an efficient drug carrier for overcoming multidrug resistance. Toxicol. Appl. Pharmacol. 2011, 250:184-193.
10. Cherukuri P., Gannon C.J., Leeuw T.K., Schmidt H.K., Smalley R.E., Curley S.A., Weisman R.B. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18882-18886.
11. Clichici S., Biris A.R., Tabaran F., Filip A. Transient oxidative stress and inflammation after intraperitoneal administration of multiwalled carbon nanotubes functionalized with single strand DNA in rats. Toxicol. Appl. Pharmacol. 2012, 259:281-292.
12. Curfs J.H., Meis J.F., Hoogkamp-Korstanje J.A. A primer on cytokines: sources, receptors, effects, and inducers. Clin. Microbiol. Rev. 1997, 10:742-780.
13. Dale D.C., Boxer L., Liles W.C. The phagocytes: neutrophils and monocytes. Blood 2008, 112:935-945.
14. Davies M.J., Hawkins C.L., Pattison D.I., Rees M.D. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signal. 2008, 10:1199-1234.
15. Delanghe J.R., Langlois M.R. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin. Chim. Acta 2001, 312:13-23.
16. Delogu L.G., Venturelli E., Manetti R., Pinna G.A., Carru C., Madeddu R., Murgia L., Sgarrella F., Dumortier H., Bianco A. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine 2012, 7:231-243.
17. Fiedler T.J., Davey C.A., Fenna R.E. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J. Biol. Chem. 1971, 275:11964-11971.
18. Furtmüller P.G., Jantschko W., Regelsberger G., Jakopitsch C., Arnhold J., Obinger C. Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 2002, 41:11895-11900.
19. Ge C., Du J., Zhao L., Wang L., Liu Y., Li D., Yang Y., Zhou R., Zhao Y., Chai Z., Chen C. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16968-16973.
20. Gustafsson A., Ljunggren L., Bodelsson M., Berkestedt I. The prognostic value of suPAR compared to other inflammatory markers in patients with severe sepsis. Biomark. Insights 2012, 7:39-44.
21. Han S., Kim S., Kwon D. Thermal/oxidative degradation and stabilization of polyethylene glycol. Polymer 1997, 38:317-323.
22. Herd Z.L., Cebra J.J. Selection of a single antigenic type of rabbit light chains by the 2,4-dinitrophenyl hapten. Immunochemistry 1970, 7:7-13.
23. Hussain S., Vanoirbeek J.A., Hoet P.H. Interactions of nanomaterials with the immune system. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4:169-183.
24. Kagan V.E., Tyurin V.A., Jiang J., Tyurina Y.Y., Ritov V.B., Amoscato A.A., Osipov A.N., Belikova N.A., Kapralov A.A., Kini V., Vlasova I.I., Zhao Q., Zou M., Di P., Svistunenko D.A., Kurnikov I.V., Borisenko G.G. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 2005, 1:223-232.
25. Kagan V.E., Konduru N.V., Feng W., Allen B.L., Conroy J., Volkov Y., Vlasova I.I., Belikova N.A., Yanamala N., Kapralov A., Tyurina Y.Y., Shi J., Kisin E.R., Murray A.R., Franks J., Stolz D., Gou P., Klein-Seetharaman J., Fadeel B., Star A., Shvedova A.A. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 2010, 5:354-359.
26. Kagan V.E., Shi J., Feng W., Shvedova A.A., Fadeel B. Fantastic voyage and opportunities of engineered nanomaterials: what are the potential risks of occupational exposures?. J. Occup. Environ. Med. 2010, 52:943-946.
27. Kapralov A., Vlasova I.I., Feng W., Maeda A., Walson K., Tyurin V.A., Huang Z., Aneja R.K., Carcillo J., Bayir H., Kagan V.E. Peroxidase activity of hemoglobin-haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages. J. Biol. Chem. 2009, 284:30395-30407.
28. Kapralov A.A., Feng W.H., Amoscato A.A., Yanamala N., Balasubramanian K., Winnica D.E., Kisin E.R., Kotchey G.P., Gou P., Sparvero L.J., Ray P., Mallampalli R.K., Klein-Seetharaman J., Fadeel B., Star A., Shvedova A.A., Kagan V.E. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 2012, 22(6):4147-4156.
29. Kettle A.J., Winterbourn C.C. Assays for the chlorination activity of myeloperoxidase. Meth. Enzymol. 1994, 233:502-512.
30. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 2005, 77:598-625.
31. Kostarelos K., Bianco A., Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 2009, 4:627-633.
32. Kotchey G.P., Allen B.L., Vedala H., Yanamala N., Kapralov A.A., Tyurina Y.Y., Klein-Seetharaman J., Kagan V.E., Star A. The enzymatic oxidation of graphene oxide. ACS Nano 2011, 5:2098-2108.
33. Kotchey, G.P., Hasan, S.A., Kapralov, A.A., Ha, S.H., Kim, K., Shvedova, A.A., Kagan, V.E., Star, A., in press. A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. Acc. Chem. Res. http://pubs.acs.org/doi/pdf/10.1021/ar300106h.
34. Liang F., Chen B. A review on biomedical applications of single-walled carbon nanotubes. Curr. Med. Chem. 2010, 17:10-24.
35. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1:50-56.
36. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68:6652-6660.
37. Liu Z., Davis C., Cai W., He L., Chen X., Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1410-1415.
38. Liu Z., Tabakman S., Welsher K., Dai H. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res. 2009, 2:85-120.
39. Liu X., Hurt R.H., Kane A.B. Biodurability of single-walled carbon nanotubes depends on surface functionalization. Carbon 2010, 48:1961-1969.
40. Medepalli K., Alphenaar B., Raj A., Sethu P. Evaluation of the direct and indirect response of blood leukocytes to carbon nanotubes (CNTs). Nanomedicine 2011, 7:983-991.
41. high polymorphonuclear neutrophils in the murine abdominal cavity. Clin. Diagn. Lab. Immunol. 2004, 11:452-457.
42. Montes-Fonseca S.L., Orrantia-Borunda E., Aguilar-Elguezabal A., González Horta C., Talamás-Rohana P., Sánchez-Ramírez B. Cytotoxicity of functionalized carbon nanotubes in J774A macrophages. Nanomedicine 2012, 8:853-859.
43. Muller J., Delos M., Panin N., Rabolli V., Huaux F., Lison D. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol. Sci. 2009, 110:442-448.
44. Murphy F.A., Poland C.A., Duffin R., Al-Jamal K.T., Ali-Boucetta H., Nunes A., Byrne F., Prina-Mello A., Volkov Y., Li S., Mather S.J., Bianco A., Prato M., MacNee W., Wallace W.A., Kostarelos K., Donaldson K. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 2011, 178:2587-2600.
45. Nauseef W.M. Isolation of human neutrophils from venous blood. Methods Mol. Biol. 2007, 412:15-20.
46. Patlolla A., McGinnis B., Tchounwou P. Biochemical and histopathological evaluation of functionalized single-walled carbon nanotubes in Swiss-Webster mice. J. Appl. Toxicol. 2010, 31:75-83.
47. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A., Seaton A., Stone V., Brown S., Macnee W., Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3:423-428.
48. Prato M., Kostarelos K., Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res. 2008, 41:60-68.
49. Puppo A., Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent?. Biochem. J. 1988, 249:185-190.
50. Robinson J.T., Welsher K., Tabakman S.M., Sherlock S.P., Wang H., Luong R., Dai H. High performance in vivo near-IR (>1 μm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res. 2010, 3:779-793.
51. Russier J., Ménard-Moyon C., Venturelli E., Gravel E., Marcolongo G., Meneghetti M., Doris E., Bianco A. Oxidative biodegradation of single- and multi-walled carbon nanotubes. Nanoscale 2011, 3:893-896.
52. Schipper M.L., Nakayama-Ratchford N., Davis C.R., Kam N.W., Chu P., Liu Z., Sun X., Dai H., Gambhir S.S. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 2008, 3:218-221.
53. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.-K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L698-L708.
54. Shvedova A.A., Fabisiak J.P., Kisin E.R., Murray A.R., Roberts J.R., Tyurina Y.Y., Antonini J.M., Feng W.H., Kommineni C., Reynolds J., Barchowsky A., Castranova V., Kagan V.E. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am. J. Respir. Cell Mol. Biol. 2008, 38:579-590.
55. Shvedova A.A., Kagan V.E., Fadeel B. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu. Rev. Pharmacol. Toxicol. 2010, 50:63-88.
56. Shvedova A.A., Kapralov A.A., Feng W.H., Kisin E.R., Murray A.R., Mercer R.R., C.M.St.Croix, Lang M.A., Watkins S.C., Konduru N.V., Allen B.L., Conroy J., Kotchey G.P., Mohamed B.M., Meade A.D., Volkov Y., Star A., Fadeel B., Kagan V.E. Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One 2012, 7:e30923.
57. Shvedova A.A., Pietroiusti A., Fadeel B., Kagan V.E. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol. Appl. Pharmacol. 2012, 261:121-133.
58. Silberstein E.B., Ingraham S.C., Kereiakes J.G. The determination of optimum glycine concentration for the preparation of human fibrinogen at ambient temperatures. Thromb. Diath. Haemorrh. 1973, 29:572-578.
59. 2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery. Infection 1994, 22:386-389.
60. Sokolov A.V., Pulina M.O., Ageeva K.V., Ayrapetov M.I., Berlov M.N., Volgin G.N., Markov A.G., Yablonsky P.K., Kolodkin N.I., Zakharova E.T., Vasilyev V.B. Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase. Biochemistry (Mosc) 2007, 72:409-415.
61. Sokolov A.V., Ageeva K.V., Cherkalina O.S., Pulina M.O., Zakharova E.T., Prozorovskii V.N., Aksenov D.V., Vasilyev V.B., Panasenko O.M. Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin. Chem. Phys. Lipids 2010, 163:347-355.
62. Spalteholz H., Panasenko O.M., Arnhold J. Formation of reactive halide species by myeloperoxidase and eosinophil peroxidase. Arch. Biochem. Biophys. 2006, 445:225-234.
63. Stauffer C.E. A linear standard curve for the Folin Lowry determination of protein. Anal. Biochem. 1975, 69:646-648.
64. Sutherland K., Mahoneym J.R., Coury A.J., Eatonil J.W. Degradation of biomaterials by phagocyte-derived oxidants. J. Clin. Invest. 1993, 92:2360-2367.
65. Tang W.H., Brennan M.L., Philip K., Tong W., Mann S., Van Lente F., Hazen S.L. Plasma myeloperoxidase levels in patients with chronic heart failure. Am. J. Cardiol. 2006, 98:796-799.
66. 2 pool generated by human neutrophils. J. Biol. Chem. 1984, 259:399-405.
67. Tkach A.V., Shurin G.V., Shurin M.R., Kisin E.R., Murray A.R., Young S.H., Star A., Fadeel B., Kagan V.E., Shvedova A.A. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 2011, 5:5755-5762.
68. Vlasova I.I., Arnhold J., Osipov A.N., Panasenko O.M. pH-dependent regulation of myeloperoxidase activity. Biochemistry (Mosc) 2006, 71:667-677.
69. Vlasova I.I., Sokolov A.V., Chekanov A.V., Kostevich V.A., Vasilyev V.B. Myeloperoxidase-induced biodegradation of single-walled carbon nanotubes is mediated by hypochlorite. Russ. J. Bioorg. Chem. 2011, 37:453-463.
70. Vlasova I.I., Vakhrusheva T.V., Sokolov A.V., Kostevich V.A., Ragimov A.A. Peroxidase-induced degradation of single-walled carbon nanotubes: hypochlorite is a major oxidant capable of in vivo degradation of carbon nanotubes. J. Phys. Conf. Ser. 2011, 291(012056).
71. Vlasova I.I., Sokolov A.V., Arnhold J. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase. J. Inorg. Biochem. 2012, 106:76-83.
72. Weening R.S., Roos D., Loos J.A. Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J. Lab. Clin. Med. 1974, 83:570-577.
73. Wu S.H. Studies of the equilibrium and thermodynamics of the adsorption of Cu(2+) onto as-produced and modified carbon nanotubes. J. Colloid Interface Sci. 2007, 311:338-346.
74. Yang S.T., Wang X., Jia G., Gu Y., Wang T., Nie H., Ge C., Wang H., Liu Yu. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett. 2008, 181:182-189.
75. Zhang C., Yang J., Jacobs J.D., Jennings L.K. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2563-H2572.
76. Zhao Y., Allen B.L., Star A. Enzymatic degradation of multiwalled carbon nanotubes. J. Phys. Chem. A 2011, 115:9536-9544.